Korsana Biosciences, Inc. (KRSA)
31.65
+0.37
(+1.18%)
USD |
NASDAQ |
Nov 13, 16:00
31.58
-0.07
(-0.22%)
After-Hours: 19:59
Korsana Biosciences Market Cap : 1.441B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.441B |
| November 12, 2026 | 1.425B |
| November 11, 2026 | 1.450B |
| November 10, 2026 | 1.417B |
| November 09, 2026 | 1.420B |
| November 06, 2026 | 1.414B |
| November 05, 2026 | 1.386B |
| November 04, 2026 | 1.392B |
| November 03, 2026 | 1.456B |
| November 02, 2026 | 19.25M |
| October 30, 2026 | 18.33M |
| October 29, 2026 | 18.37M |
| October 28, 2026 | 18.31M |
| October 27, 2026 | 18.28M |
| October 26, 2026 | 19.51M |
| October 23, 2026 | 19.04M |
| October 22, 2026 | 20.33M |
| October 21, 2026 | 19.78M |
| October 20, 2026 | 18.87M |
| October 19, 2026 | 19.10M |
| October 16, 2026 | 19.69M |
| October 15, 2026 | 20.46M |
| October 14, 2026 | 20.87M |
| October 13, 2026 | 19.25M |
| October 12, 2026 | 20.70M |
| Date | Value |
|---|---|
| October 09, 2026 | 20.62M |
| October 08, 2026 | 20.37M |
| October 07, 2026 | 19.24M |
| October 06, 2026 | 19.32M |
| October 05, 2026 | 18.68M |
| October 02, 2026 | 18.54M |
| October 01, 2026 | 18.97M |
| September 30, 2026 | 19.46M |
| September 29, 2026 | 20.67M |
| September 28, 2026 | 18.74M |
| September 25, 2026 | 18.85M |
| September 24, 2026 | 22.61M |
| September 23, 2026 | 19.64M |
| September 22, 2026 | 21.27M |
| September 21, 2026 | 20.19M |
| September 18, 2026 | 21.27M |
| September 17, 2026 | 20.50M |
| September 16, 2026 | 18.99M |
| September 15, 2026 | 19.50M |
| September 14, 2026 | 19.22M |
| September 11, 2026 | 19.40M |
| September 10, 2026 | 14.93M |
| September 09, 2026 | 15.93M |
| September 08, 2026 | 14.30M |
| September 04, 2026 | 18.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Q32 Bio, Inc. | 260.36M |
| IRulya Therapeutics, Inc. | 40.48M |
| Climb Bio, Inc. | 598.06M |
| PepGen Inc. | 301.98M |
| Bridgebio Oncology Therapeutics, Inc. | 171.70M |
Market Cap Related Metrics
| PS Ratio | 117.95 |
| Price to Book Value | 3.681 |
| Price | 31.65 |
| Earnings Yield | -41.31% |